EpiFaith Resident Learning Curve Trial
NCT: NCT07395622 · RECRUITING
Brief Summary
This study aims to evaluate the impact of the EpiFaith® syringe on the learning curve of anesthesia residents for the labor epidural technique. Anesthesia residents with prior experience placing \< 5 labor epidurals will be enrolled. Their performance of 20 sequential labor epidural placements with either standard technique with a beveled glass syringe or the EpiFaith® syringe will be observed. Successful epidural placement over time with sequential epidural placement attempts will be measured between groups. The primary outcome will be rate of successful epidural placement. Success will be defined as a composite of 4 criteria: maximum 3 attempts for placement; no need to re-site at a different level; no required intervention by the supervising attending anesthesiologist; and adequate analgesia with a visual analog score (VAS) \<3 at 30 minutes. We hypothesize that use of the EpiFaith® syringe will enable a faster learning curve for successful epidural placement. A cumulative sum chart (CUSUM) analysis will evaluate whether the EpiFaith® syringe causes deviation from the control learning curve. Secondary outcomes will include rate of inadvertent dural puncture and epidural replacement rate.
Frequently Asked Questions
What is EpiFaith Resident Learning Curve Trial?
EpiFaith Resident Learning Curve Trial is a clinical trial registered under NCT07395622. Current status: RECRUITING.
What is the status of NCT07395622?
The current status of NCT07395622 (EpiFaith Resident Learning Curve Trial) is: RECRUITING.
When did EpiFaith Resident Learning Curve Trial start?
EpiFaith Resident Learning Curve Trial started on 2023-09-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.